XML 30 R19.htm IDEA: XBRL DOCUMENT v3.8.0.1
STOCK REPURCHASE PROGRAM
6 Months Ended
Dec. 24, 2017
Equity [Abstract]  
STOCK REPURCHASE PROGRAM
STOCK REPURCHASE PROGRAM
In November 2017, the Board of Directors authorized the Company to repurchase up to an additional $2.0 billion of Common Stock; this authorization supplements the remaining balances from any prior authorizations. These repurchases can be conducted on the open market or as private purchases and may include the use of derivative contracts with large financial institutions, in all cases subject to compliance with applicable law. Repurchases are funded using the Company’s on-shore cash, on-shore cash generation, and available credit facilities. This repurchase program has no termination date and may be suspended or discontinued at any time.
Repurchases under the repurchase program were as follows during the periods indicated:
Period
Total Number of
Shares
Repurchased
 
Total Cost of
Repurchase
 
Average Price
Paid Per Share
(1)
 
Amount
Available Under
Repurchase
Program
 
(in thousands, except per share data)
Available balance as of June 25, 2017
 
 
 
 
 
 
$
282,141

Quarter ended September 24, 2017
1,779

 
$
157,938

 
$
158.40

 
$
124,203

Board authorization $2.0 billion increase, November 2017
 
 
 
 
 
 
$
2,124,203

Quarter ended December 24, 2017
3,709

 
$
1,089,744

 
$
196.28

 
$
1,034,459


(1) Average price paid per share excludes effect of accelerated share repurchases; see additional disclosure below regarding our accelerated share repurchase activity during the fiscal year.
In addition to the shares repurchased under the Board-authorized repurchase program shown above, during the three and six months ended December 24, 2017, the Company acquired 98 thousand shares at a total cost of $18.4 million and 109 thousand shares at a total cost of $20.2 million, respectively, which the Company withheld through net settlements to cover minimum tax withholding obligations upon the vesting of restricted stock unit awards granted under the Company’s equity compensation plans. The shares retained by the Company through these net share settlements are not a part of the Board-authorized repurchase program but instead are authorized under the Company’s equity compensation plan.
Accelerated Share Repurchase Agreements Executed in December Quarter
On November 20, 2017, the Company entered into four separate accelerated share repurchase agreements (collectively, the "November 2017 ASR") with two financial institutions to repurchase a total of  $1.0 billion of Common Stock. The Company took an initial delivery of 3,254,300 shares, which represented 70% of the prepayment amount divided by the Company’s closing stock price on November 20, 2017. The total number of shares to be received under the November 2017 ASR will be based upon the average daily volume weighted average price of the Company’s Common Stock during the repurchase period, less an agreed upon discount. Final settlement of two of the transactions is expected to be completed no later than February 22, 2018, and final settlement for the remaining transactions is expected to be completed no sooner than March 26, 2018 or no later than May 24, 2018.
Accelerated Share Repurchase Agreements Settled in Fiscal Year
On April 19, 2017, the Company entered into two separate accelerated share repurchase agreements (collectively, the “April 2017 ASR”) with two financial institutions to repurchase a total of $500 million of Common Stock. The Company took an initial delivery of approximately 2,570,000 shares, which represented 70% of the prepayment amount divided by the Company’s closing stock price on April 19, 2017. The total number of shares received under the April 2017 ASR was based upon the average daily volume weighted average price of our Common Stock during the repurchase period, less an agreed upon discount. The April 2017 ASR settled on June 30, 2017. Approximately 780,000 shares were received at final settlement, which resulted in a weighted-average share price of approximately $149.16 for the transaction period.